NCT00579514: Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

NCT00579514
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER++, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: Child, Adult, Older Adult
Location of Metastases: 
Additional Notes: Patients must have donated a blood sample to Memorial Sloan Kettering Cancer Center; Patient must have Ashkenazi Jewish ancestry
Exclusions: 
https://ClinicalTrials.gov/show/NCT00579514

Comments are closed.

Up ↑